(ALV) Autoliv - Overview
Exchange: NYSE •
Country: Sweden •
Currency: USD •
Type: Common Stock •
ISIN: US0528001094
Stock: Airbags, Seatbelts, Steering Wheels, Inflators, Pedestrian Protection
Total Rating 61
Risk 88
Buy Signal 0.31
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.85% |
| Yield on Cost 5y | 3.76% |
| Yield CAGR 5y | 13.50% |
| Payout Consistency | 94.8% |
| Payout Ratio | 24.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 29.3% |
| Relative Tail Risk | -0.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.10 |
| Alpha | 22.38 |
| Character TTM | |
|---|---|
| Beta | 0.916 |
| Beta Downside | 0.811 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.27% |
| CAGR/Max DD | 0.39 |
Description: ALV Autoliv January 07, 2026
Autoliv Inc. (NYSE: ALV) designs, manufactures, and supplies a broad portfolio of passive safety systems-including frontal- and side-impact airbags, pedestrian-protection modules, steering-wheel components, inflators, battery-cut-off switches, and seat-belt assemblies-to OEMs across Europe, the Americas, China, Japan, and the rest of Asia. The firm also offers mobility-safety services for powered-two-wheelers and connected-vehicle safety solutions.
Key operating metrics (FY 2023) show revenue of roughly $8.5 billion and an adjusted EBIT margin near 10 %, reflecting steady demand for safety equipment amid tightening global crash-safety regulations. Growth exposure is tied to the electric-vehicle transition (higher airbag-inflator counts per vehicle) and OEM consolidation, which can amplify bargaining power but also create larger, more stable contracts.
For a deeper quantitative view of ALV’s valuation metrics, you may find the ValueRay platform useful.
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 752.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.30 > 1.0 |
| NWC/Revenue: 1.68% < 20% (prev -1.43%; Δ 3.10% < -1%) |
| CFO/TA 0.12 > 3% & CFO 1.03b > Net Income 752.0m |
| Net Debt (1.67b) to EBITDA (1.45b): 1.15 < 3 |
| Current Ratio: 1.05 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (80.4m) vs prev -5.63% < -2% |
| Gross Margin: 19.33% > 18% (prev 0.18%; Δ 1915 % > 0.5%) |
| Asset Turnover: 129.1% > 50% (prev 134.9%; Δ -5.82% > 0%) |
| Interest Coverage Ratio: 11.08 > 6 (EBITDA TTM 1.45b / Interest Expense TTM 101.0m) |
Altman Z'' 2.11
| A: 0.02 (Total Current Assets 4.10b - Total Current Liabilities 3.92b) / Total Assets 8.64b |
| B: 0.24 (Retained Earnings 2.10b / Total Assets 8.64b) |
| C: 0.14 (EBIT TTM 1.12b / Avg Total Assets 8.22b) |
| D: 0.25 (Book Value of Equity 1.53b / Total Liabilities 6.06b) |
| Altman-Z'' Score: 2.11 = BBB |
Beneish M -3.08
| DSRI: 1.11 (Receivables 2.24b/1.99b, Revenue 10.61b/10.53b) |
| GMI: 0.94 (GM 19.33% / 18.12%) |
| AQI: 0.90 (AQ_t 0.22 / AQ_t-1 0.25) |
| SGI: 1.01 (Revenue 10.61b / 10.53b) |
| TATA: -0.03 (NI 752.0m - CFO 1.03b) / TA 8.64b) |
| Beneish M-Score: -3.08 (Cap -4..+1) = AA |
What is the price of ALV shares?
As of February 07, 2026, the stock is trading at USD 125.79 with a total of 676,282 shares traded.
Over the past week, the price has changed by +3.75%, over one month by +0.50%, over three months by +5.72% and over the past year by +37.74%.
Over the past week, the price has changed by +3.75%, over one month by +0.50%, over three months by +5.72% and over the past year by +37.74%.
Is ALV a buy, sell or hold?
Autoliv has received a consensus analysts rating of 3.83.
Therefore, it is recommended to buy ALV.
- StrongBuy: 7
- Buy: 3
- Hold: 7
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the ALV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 138.7 | 10.3% |
| Analysts Target Price | 138.7 | 10.3% |
| ValueRay Target Price | 148.6 | 18.1% |
ALV Fundamental Data Overview January 31, 2026
P/E Trailing = 13.1016
P/E Forward = 11.2613
P/S = 0.9149
P/B = 3.7679
P/EG = 0.8491
Revenue TTM = 10.61b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.45b USD
Long Term Debt = 1.52b USD (from longTermDebt, last fiscal year)
Short Term Debt = 419.0m USD (from shortTermDebt, last quarter)
Debt = 2.27b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.67b USD (from netDebt column, last quarter)
Enterprise Value = 11.38b USD (9.71b + Debt 2.27b - CCE 604.0m)
Interest Coverage Ratio = 11.08 (Ebit TTM 1.12b / Interest Expense TTM 101.0m)
EV/FCF = 19.93x (Enterprise Value 11.38b / FCF TTM 571.0m)
FCF Yield = 5.02% (FCF TTM 571.0m / Enterprise Value 11.38b)
FCF Margin = 5.38% (FCF TTM 571.0m / Revenue TTM 10.61b)
Net Margin = 7.08% (Net Income TTM 752.0m / Revenue TTM 10.61b)
Gross Margin = 19.33% ((Revenue TTM 10.61b - Cost of Revenue TTM 8.56b) / Revenue TTM)
Gross Margin QoQ = 19.29% (prev 18.46%)
Tobins Q-Ratio = 1.32 (Enterprise Value 11.38b / Total Assets 8.64b)
Interest Expense / Debt = 1.10% (Interest Expense 25.0m / Debt 2.27b)
Taxrate = 27.08% (65.0m / 240.0m)
NOPAT = 815.9m (EBIT 1.12b * (1 - 27.08%))
Current Ratio = 1.05 (Total Current Assets 4.10b / Total Current Liabilities 3.92b)
Debt / Equity = 0.88 (Debt 2.27b / totalStockholderEquity, last quarter 2.57b)
Debt / EBITDA = 1.15 (Net Debt 1.67b / EBITDA 1.45b)
Debt / FCF = 2.93 (Net Debt 1.67b / FCF TTM 571.0m)
Total Stockholder Equity = 2.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.14% (Net Income 752.0m / Total Assets 8.64b)
RoE = 30.26% (Net Income TTM 752.0m / Total Stockholder Equity 2.49b)
RoCE = 27.92% (EBIT 1.12b / Capital Employed (Equity 2.49b + L.T.Debt 1.52b))
RoIC = 18.06% (NOPAT 815.9m / Invested Capital 4.52b)
WACC = 7.68% (E(9.71b)/V(11.99b) * Re(9.29%) + D(2.27b)/V(11.99b) * Rd(1.10%) * (1-Tc(0.27)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.27%
[DCF Debug] Terminal Value 79.60% ; FCFF base≈539.4m ; Y1≈551.3m ; Y5≈609.7m
Fair Price DCF = 128.0 (EV 11.39b - Net Debt 1.67b = Equity 9.72b / Shares 76.0m; r=7.68% [WACC]; 5y FCF grow 2.06% → 2.90% )
EPS Correlation: 75.03 | EPS CAGR: 68.59% | SUE: 0.95 | # QB: 2
Revenue Correlation: 84.08 | Revenue CAGR: 6.74% | SUE: 0.12 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.36 | Chg30d=+0.033 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-12-31): EPS=11.01 | Chg30d=-0.004 | Revisions Net=-2 | Growth EPS=+11.7% | Growth Revenue=+3.4%
EPS next Year (2027-12-31): EPS=12.47 | Chg30d=+0.026 | Revisions Net=+2 | Growth EPS=+13.3% | Growth Revenue=+4.1%
P/E Forward = 11.2613
P/S = 0.9149
P/B = 3.7679
P/EG = 0.8491
Revenue TTM = 10.61b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.45b USD
Long Term Debt = 1.52b USD (from longTermDebt, last fiscal year)
Short Term Debt = 419.0m USD (from shortTermDebt, last quarter)
Debt = 2.27b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.67b USD (from netDebt column, last quarter)
Enterprise Value = 11.38b USD (9.71b + Debt 2.27b - CCE 604.0m)
Interest Coverage Ratio = 11.08 (Ebit TTM 1.12b / Interest Expense TTM 101.0m)
EV/FCF = 19.93x (Enterprise Value 11.38b / FCF TTM 571.0m)
FCF Yield = 5.02% (FCF TTM 571.0m / Enterprise Value 11.38b)
FCF Margin = 5.38% (FCF TTM 571.0m / Revenue TTM 10.61b)
Net Margin = 7.08% (Net Income TTM 752.0m / Revenue TTM 10.61b)
Gross Margin = 19.33% ((Revenue TTM 10.61b - Cost of Revenue TTM 8.56b) / Revenue TTM)
Gross Margin QoQ = 19.29% (prev 18.46%)
Tobins Q-Ratio = 1.32 (Enterprise Value 11.38b / Total Assets 8.64b)
Interest Expense / Debt = 1.10% (Interest Expense 25.0m / Debt 2.27b)
Taxrate = 27.08% (65.0m / 240.0m)
NOPAT = 815.9m (EBIT 1.12b * (1 - 27.08%))
Current Ratio = 1.05 (Total Current Assets 4.10b / Total Current Liabilities 3.92b)
Debt / Equity = 0.88 (Debt 2.27b / totalStockholderEquity, last quarter 2.57b)
Debt / EBITDA = 1.15 (Net Debt 1.67b / EBITDA 1.45b)
Debt / FCF = 2.93 (Net Debt 1.67b / FCF TTM 571.0m)
Total Stockholder Equity = 2.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.14% (Net Income 752.0m / Total Assets 8.64b)
RoE = 30.26% (Net Income TTM 752.0m / Total Stockholder Equity 2.49b)
RoCE = 27.92% (EBIT 1.12b / Capital Employed (Equity 2.49b + L.T.Debt 1.52b))
RoIC = 18.06% (NOPAT 815.9m / Invested Capital 4.52b)
WACC = 7.68% (E(9.71b)/V(11.99b) * Re(9.29%) + D(2.27b)/V(11.99b) * Rd(1.10%) * (1-Tc(0.27)))
Discount Rate = 9.29% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.27%
[DCF Debug] Terminal Value 79.60% ; FCFF base≈539.4m ; Y1≈551.3m ; Y5≈609.7m
Fair Price DCF = 128.0 (EV 11.39b - Net Debt 1.67b = Equity 9.72b / Shares 76.0m; r=7.68% [WACC]; 5y FCF grow 2.06% → 2.90% )
EPS Correlation: 75.03 | EPS CAGR: 68.59% | SUE: 0.95 | # QB: 2
Revenue Correlation: 84.08 | Revenue CAGR: 6.74% | SUE: 0.12 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.36 | Chg30d=+0.033 | Revisions Net=+0 | Analysts=7
EPS current Year (2026-12-31): EPS=11.01 | Chg30d=-0.004 | Revisions Net=-2 | Growth EPS=+11.7% | Growth Revenue=+3.4%
EPS next Year (2027-12-31): EPS=12.47 | Chg30d=+0.026 | Revisions Net=+2 | Growth EPS=+13.3% | Growth Revenue=+4.1%